PARIS, France—The evolution of self-expanding TAVR devices has enabled researchers to improve outcomes across a wide range of patients. Two studies presented May 20, 2015, at EuroPCR explore results ...
A randomized clinical trial comparing Medtronic's ($MDT) CoreValve to Edwards' ($EW) Sapien XT concluded that the clinical outcomes of the patients' receiving either ...
Five-year data for novel cardiology devices are often unavailable before that iteration of the device has become obsolete, but those data are nonetheless important. Hans Gustav Thyregod of Copenhagen ...
Medtronic's CoreValve transcatheter aortic valve replacement system continued to report positive data at two years for high-risk patients. The study shows the efficacy of TAVR for high-risk patients ...
Irvine, CA - A court injunction preventing the sale of Medtronic's CoreValve in Germany went into effect yesterday, the manufacturer of the CoreValve's chief competitor, Edwards Lifesciences, ...
The number and quality of TAVR devices available to US clinicians is growing, as demonstrated by the recent approvals of the Sapien 3 transcatheter heart valve and the CoreValve Evolut R. With results ...
October 10, 2012 (London, United Kingdom) — New data--including results from registries in Latin America, Asia, and parts of Europe--suggest that rates of pacemaker implantation following ...
Leading medical device major Medtronic Inc.'s (MDT) self-expanding CoreValve transcatheter aortic valve system recently exhibited cost efficiency in transcatheter aortic valve replacement (:TAVR) ...
DUBLIN and CHICAGO - April 3, 2016 - Medtronic plc (MDT) today announced new data from the High Risk Study of the CoreValve U.S. Pivotal Trial that show superior clinical outcomes for transcatheter ...
Please provide your email address to receive an email when new articles are posted on . Medtronic announced that the FDA has approved its self-expanding transcatheter CoreValve System for patients ...
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) announced today it has signed a definitive agreement to acquire CoreValve, Inc., developer of a transcatheter, transfemoral aortic valve ...
IRVINE, Calif.--(BUSINESS WIRE)--CoreValve (www.corevalve.com) announced today that it has signed a definitive agreement to be acquired by Medtronic, Inc. (NYSE: MDT). CoreValve’s transcatheter, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback